This historical case report details the prolonged clinical course of a patient with severe cardiac decompensation lasting 14 months.
Answers are grounded in this paper and cite their sources.
Documents 14-month decompensation in detail; leaves open generalizability to contemporary HF.
Article1 September 1932Cardiac FailureReport of a Case of Cardiac Decompensation of Fourteen Months DurationEDWARD J. STIEGLITZ, M.S., M.D., F.A.C.P.EDWARD J. STIEGLITZ, M.S., M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-6-3-406 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptIt is most unusual for cardiac decompensation with severe edema to persist for as long as fourteen months. Cardiac failure and its associated phenomena have been repeatedly described and discussed, but the present instance permitted of long and careful study throughout the latter course of the decompensation, and revealed a number of most significant phenomena which warrant discussion.REPORT OF CASEThe patient, a widow with one child, was first seen June 25, 1928, at which time she was 55 years old. The chief complaint was marked dyspnea, occurring particularly upon exertion, but noticeable even at rest or when talking...References1 STIEGLITZ EJ: Arterial hypertension; evaluation of prognosis, Arch. Int. Med., 1930, xlvi, 227-235. CrossrefGoogle Scholar2 POSTSTIEGLITZ WEEJ: Hypertension; clinical aspects of etiology and therapy, Am. Jr. Med. Sci., 1926, clxxi, 648-654. CrossrefGoogle Scholar3 STIEGLITZ EJ: Arterial hypertension, 1930, Hoeber, New York. Google Scholar4 STIEGLITZ EJ: Bismuth subnitrate in therapy of hypertension, Jr. Pharmacol. and Exper. Therap., 1927, xxxii, 23-35. Google Scholar5 STIEGLITZ EJ: Bismuth subnitrate in the treatment of arterial hypertension, Jr. Am. Med. Assoc., 1930, xcv, 842-846. CrossrefGoogle Scholar6 STIEGLITZ EJ: Pharmacodynamics and value of bismuth subnitrate in hypertension, Jr. Pharmacol. and Exper. Therap., 1928, xxxiv, 407-423. Google Scholar7 MARGOLISZIELLESSENBARNES HMFOAR: Calcareous aortic valvular disease, Am. Heart Jr., 1931, vi, 349, 374. CrossrefGoogle Scholar8 ALDRICHMCCLURE CAWB: Time required for disappearance of intradermally injected salt solution, Jr. Am. Med. Assoc., 1923, lxxxi, 293-294. Google Scholar9 BAKER WJ: Intradermal salt solution test in scarlet fever and diphtheria patients, Jr. Am. Med. Assoc., 1924, lxxxiii, 1566-1567. CrossrefGoogle Scholar10 ALDRICHMCCLURE CAWB: The intradermal salt solution test, Jr. Am. Med. Assoc., 1924, lxxxii, 1425-1428. CrossrefGoogle Scholar11 OLMSTEAD EC: Intradermal salt solution test in cardiac disease in children, Arch. Int. Med., 1925, xxxvii, 281-290. Google Scholar12 BRAMS WA: The effect of digitalis on the electrocardiogram, Arch. Int. Med., 1929, xliii, 676-683. CrossrefGoogle Scholar13 EGGLESTON C: Influence of large doses of digitalis and digitoxin on the blood pressures in man, Jr. Am. Med. Assoc., 1917, lxix, 951-955. CrossrefGoogle Scholar14 HATCHEREGGLESTON RAC: Observations on the keeping properties of digitalis and some of its preparations, Am. Jr. Pharm., 1913, lxxxv, 203-214. Google Scholar15 SCHOLZ W: Die Behandlung der Herzschwäche, Wien. klin. Wchnschr., 1928, xli, 1283. Google Scholar16 EGGLESTON C: Digitalis dosage, Arch. Int. Med., 1915, xvi, 1-32. CrossrefGoogle Scholar17 LEVYMACKIE RLTT: Drug treatment of heart disease, Jr. Am. Med. Assoc., 1927, lxxxix, 432-436. CrossrefGoogle Scholar18 CLOETTA M: The biochemical action of digitalis, Jr. Am. Med. Assoc., 1929, xciii, 1462-1463. CrossrefGoogle Scholar19 HATCHEREGGLESTON RAC: The emetic action of the digitalis bodies, Jr. Pharmacol, and Exper. Therap., 1912, iv, 113-134. Google Scholar20 HATCHERWEISS RAS: The seat of emetic action of the digitalis bodies, Arch. Int. Med., 1922, xxix, 690-704 CrossrefGoogle Scholar21 HATCHERWEISS RAS: Reflex vomiting from heart; mechanism of vomiting induced by digitalis bodies, Jr. Am. Med. Assoc., 1927, lxxxix, 429-432. CrossrefGoogle Scholar22 LANKFORD JS: Future of medicine, Clin. Med. and Surg., 1930, xxxvii, 516-520. Google Scholar23 MALONEY AH: Studies on respiratory stimulants and depressants, Jr. Pharmacol. and Exper. Therap., 1930, xxxix, 264-265. Google Scholar24 LEYKO E: Action of some heart tonics, Jr. Pharmacol. and Exper. Therap., 1930, xxxviii, 31-49. Google Scholar25 SCUÜBELGEHLEN KW: Vergleichende Untersuchungen über atmungserregende Pharmaka am morphinvergifteten Kaninchen, Arch. f. exper. Path. u. Pharmakol., 1928, cxxxiii, 295-316. CrossrefGoogle Scholar26 EISNER W: Klinische Untersuchungen über den Einfluss des Coramins auf die Überleitungszeit des Herzens, Schweiz, med. Wchnschr., 1927, lvii, 574. Google Scholar27 SMITHGIBSONROSS FMRBNG: The diet in the treatment of cardiac failure, Jr. Am. Med. Assoc., 1927, lxxxviii, 1943-1947. CrossrefGoogle Scholar28 SMITH HL: Digitalis delirium with colored vision; report of one case, Jr. Iowa Med. Soc., 1931, xxi, 173-174. Google Scholar29 CORNWALL EE: Clinical significance of variations in the systolic and diastolic blood pressures and the pulse pressure, Internat. Clin., 1915, xxv, s. i, 151-168. Google Scholar30 READ JM: Clinical interpretation of pulse pressure, Abridged in Cal. and West. Med., 1929, xxvii, 211-212. Google Scholar31 READ JM: A clinical interpretation of pulse pressure, Am. Heart Jr., 1927, ii, 541-547. CrossrefGoogle Scholar32 CHRISTIAN HA: Aortic stenosis with calcification of the cusps, Jr. Am. Med. Assoc., 1931, xcvii, 158-161. CrossrefGoogle Scholar33 KEEFERRESNICK CSWH: Angina pectoris; syndrome caused by the anoxemia of myocardium, Arch. Int. Med., 1928, xli, 764-807. Google Scholar34 LOEB J: Proteins and the theory of colloidal behavior, 1922, McGraw-Hill, New York. CrossrefGoogle Scholar35 FISCHER M: Edema and nephritis, 1915, John Wiley & Sons, New York. Google Scholar36 LOEB L: Edema, 1923, Williams & Wilkins, Baltimore. CrossrefGoogle Scholar37 ANDREWS E: Experimental uremia, Arch. Int. Med., 1927, xl, 548-570. CrossrefGoogle Scholar38 MCELROY JB: Diseases of the kidney, Tice's Practise of Medicine, 1921, W. F. Prior Company, Inc., Hagerstown, vi, 581. Google Scholar39 KEITHWHELANBANNICK NMMEG: Action and excretion of nitrates, Arch. Int. Med., 1930, xlvi, 797-832. CrossrefGoogle Scholar40 STIEGLITZ EJ: Alkalis and renal injury, Arch. Int. Med., 1928, xli, 10-17. CrossrefGoogle Scholar41 EPSTEIN AA: Quoted in Bannick, E. G., and Keith, N. M.: The treatment of nephritis and nephrosis with edema, Jr. Am. Med. Assoc., 1928, xci, 1944-1952. Google Scholar42 BLANDWHITE EFPD: The use of mechanical measures in the treatment of obstinate edema, Jr. Am. Med. Assoc., 1930, xcv, 1489-1493. CrossrefGoogle Scholar43 LIEBERMAN AL: Comparative studies on calcium gluconate and other calcium salts, Jr. Am. Med. Assoc., 1931, xcvii, 15-16. CrossrefGoogle Scholar44 BARACH AL: Therapeutic use of oxygen in heart disease, ANN. INT. MED., 1931, v, 428-440. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Chicago, Ill.Received for publication, October 29, 1931. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byCardiac disease in obstetrics 1 September 1932Volume 6, Issue 3Page: 406-421KeywordsDyspneaEdemaHeart failure Issue Published: 1 September 1932 PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Edward J. Stieglitz (1932) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: